Indication
Acanthamoeba Keratitis
3 clinical trials
9 products
Clinical trial
Randomized, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% PHMB Ophthalmic Solution in Comparison With 0.02% PHMB + 0.1% Propamidine Combination Therapy in Subjects Affected by Acanthamoeba KeratitisStatus: Completed, Estimated PCD: 2021-06-30
Product
PropamidineProduct
placeboProduct
PHMBProduct
Polyhexamethylene biguanideProduct
Topical corticosteroidClinical trial
Parasitic Ulcer Treatment Trial PilotStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
ChlorhexidineProduct
Povidone-Iodine